Stryker Corporation (SYK)
NYSE: SYK · Real-Time Price · USD
369.59
-6.34 (-1.69%)
At close: Oct 29, 2025, 4:00 PM EDT
371.99
+2.40 (0.65%)
After-hours: Oct 29, 2025, 7:54 PM EDT
Stryker Market Cap
Stryker has a market cap or net worth of $141.3 billion as of October 29, 2025. Its market cap has increased by 4.27% in one year.
Market Cap
141.30B
Enterprise Value
155.96B
1-Year Change
4.27%
Ranking
Category
Stock Price
$369.59
Market Cap Chart
Since December 1, 1998, Stryker's market cap has increased from $4.26B to $141.30B, an increase of 3,220.10%. That is a compound annual growth rate of 13.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 143.72B | 4.71% |
| Dec 31, 2024 | 137.26B | 20.65% |
| Dec 29, 2023 | 113.76B | 22.96% |
| Dec 30, 2022 | 92.52B | -8.29% |
| Dec 31, 2021 | 100.88B | 9.55% |
| Dec 31, 2020 | 92.08B | 17.16% |
| Dec 31, 2019 | 78.59B | 34.00% |
| Dec 31, 2018 | 58.65B | 1.22% |
| Dec 29, 2017 | 57.95B | 29.16% |
| Dec 30, 2016 | 44.86B | 28.54% |
| Dec 31, 2015 | 34.90B | -2.20% |
| Dec 31, 2014 | 35.69B | 25.51% |
| Dec 31, 2013 | 28.43B | 36.42% |
| Dec 31, 2012 | 20.84B | 9.57% |
| Dec 30, 2011 | 19.02B | -10.80% |
| Dec 31, 2010 | 21.33B | 6.45% |
| Dec 31, 2009 | 20.03B | 24.21% |
| Dec 31, 2008 | 16.13B | -47.41% |
| Dec 31, 2007 | 30.67B | 36.69% |
| Dec 29, 2006 | 22.44B | 24.71% |
| Dec 30, 2005 | 17.99B | -7.24% |
| Dec 31, 2004 | 19.40B | 14.38% |
| Dec 31, 2003 | 16.96B | 27.63% |
| Dec 31, 2002 | 13.29B | 15.78% |
| Dec 31, 2001 | 11.48B | 15.98% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 736.23B |
| Johnson & Johnson | 449.42B |
| AbbVie | 402.05B |
| UnitedHealth Group | 333.14B |
| AstraZeneca | 255.54B |
| Novartis AG | 250.89B |
| Novo Nordisk | 229.86B |
| Abbott Laboratories | 220.36B |